Crinetics Pharmaceuticals, Inc.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Crinetics Pharmaceuticals, Inc. - overview
Established
2008
Location
San Diego, CA, US
Primary Industry
Pharmaceuticals
About
Founded in 2008 and based in California, US, Crinetics Pharmaceuticals Inc. is a pharmaceutical company that manufactures and distributes medical drugs for endocrine diseases and cancer. These drugs include an oral selective nonpeptide somatostatin receptor type 2 biased agonist, a treatment for acromegaly; an oral selective nonpeptide somatostatin type 5 receptor agonist, a treatment for congenital hyperinsulinism; and an oral, selective nonpeptide sst2 biased agonist, a treatment for neuroendocrine tumors.
Current Investors
OrbiMed Advisors, Versant Ventures, 5AM Ventures
Primary Industry
Pharmaceuticals
Sub Industries
Biopharmaceuticals, Oncology/Cancer Treatment, Pharmaceutical Research & Development
Website
www.crinetics.com
Company Stage
Mature
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.